Hudson County is halting their usage of the Johnson & Johnson COVID-19 following the recommendations of the Food and Drug Administration and the U.S. Centers for Disease Control, with Moderna and Pfizer vaccines to proceed as scheduled.
“After reviewing the new information released from the CDC and consulting with our own experts, Hudson County has decided to proceed with caution and suspend administering the Johnson & Johnson vaccine,” Hudson County Executive Tom DeGise said in a statement.
“Our vaccination site at the USS Juneau Center remains open for all eligible residents who will continue to be cared for under the watchful eye of the Hudson Regional Health Commission, which has done a remarkable job vaccinating our community safely and efficiently.”
The FDA said this morning that the New Brunswick-based pharmaceutical company had administered around 6.8 million vaccinations across the country.
They are reviewing the circumstances related to six women who received the vaccine and developed rare and severe blood clots between six and 13 days after being vaccinated.
Hudson County’s decision follows New Jersey Health Commissioner Judy Persichilli deciding that they would be pausing J&J vaccinations statewide.
” … The New Jersey Department of Health this morning paused the administration of the Johnson & Johnson (Janssen) vaccine across all vaccination sites in the state,” she said.